EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

NCT00035100 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms

Interventions

DRUG: epothilone b

Sponsor

Novartis Pharmaceuticals